TEMOBIC: A ANOCEF phase II study of BCNU and temozolomide (TMZ) combination prior to radiotherapy (RT) in anaplasic oligodendroglial gliomas (AOG).
O. L. Chinot
Honoraria - Schering-Plough
Research Funding - Schering-Plough
K. Hoang-Xuan
No relevant relationships to disclose
M. Fabbro
No relevant relationships to disclose
L. Taillandier
No relevant relationships to disclose
J. Honnorat
No relevant relationships to disclose
M. Barrie
No relevant relationships to disclose
M. Sanson
No relevant relationships to disclose
C. Kerr
No relevant relationships to disclose
P. Beauchesne
No relevant relationships to disclose
S. Cartalat-Carel
No relevant relationships to disclose
D. Autran
No relevant relationships to disclose
A. Loundou
No relevant relationships to disclose
R. Guillevin
No relevant relationships to disclose
K. Mokhtari
No relevant relationships to disclose
D. Figarella-Branger
No relevant relationships to disclose
J. Delattre
No relevant relationships to disclose